Outcomes in Temporary ICUs Versus Conventional ICUs: An Observational Cohort of Mechanically Ventilated Patients With COVID-19-Induced Acute Respiratory Distress Syndrome

IMPORTANCE: Throughout the COVID-19 pandemic, thousands of temporary ICUs have been established worldwide. The outcomes and management of mechanically ventilated patients in these areas remain unknown. OBJECTIVES: To investigate mortality and management of mechanically ventilated patients in tempora...

Full description

Saved in:
Bibliographic Details
Published inCritical care explorations Vol. 4; no. 4; p. e0668
Main Authors Jimenez, Jose Victor, Olivas-Martinez, Antonio, Rios-Olais, Fausto Alfredo, Ayala-Aguillón, Frida, Gil- López, Fernando, Leal-Villarreal, Mario Andrés de Jesús, Rodríguez-Crespo, Juan José, Jasso-Molina, Juan C., Enamorado-Cerna, Linda, Dardón-Fierro, Francisco Eduardo, Martínez-Guerra, Bernardo A., Román-Montes, Carla Marina, Alvarado-Avila, Pedro E., Juárez-Meneses, Noé Alonso, Morales-Paredes, Luis Alberto, Chávez-Suárez, Adriana, Gutierrez-Espinoza, Irving Rene, Najera-Ortíz, María Paula, Martínez-Becerril, Marina, Gonzalez-Lara, María Fernanda, Ponce de León-Garduño, Alfredo, Baltazar-Torres, José Ángel, Rivero-Sigarroa, Eduardo, Dominguez-Cherit, Guillermo, Hyzy, Robert C., Kershenobich, David, Sifuentes-Osornio, José
Format Journal Article
LanguageEnglish
Published Hagerstown, MD Lippincott Williams & Wilkins 01.04.2022
Wolters Kluwer
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:IMPORTANCE: Throughout the COVID-19 pandemic, thousands of temporary ICUs have been established worldwide. The outcomes and management of mechanically ventilated patients in these areas remain unknown. OBJECTIVES: To investigate mortality and management of mechanically ventilated patients in temporary ICUs. DESIGN, SETTING, AND PARTICIPANTS: Observational cohort study in a single-institution academic center. We included all adult patients with severe COVID-19 hospitalized in temporary and conventional ICUs for invasive mechanical ventilation due to acute respiratory distress syndrome from March 23, 2020, to April 5, 2021. MAIN OUTCOMES AND MEASURES: To determine if management in temporary ICUs increased 30-day in-hospital mortality compared with conventional ICUs. Ventilator-free days, ICU-free days (both at 28 d), hospital length of stay, and ICU readmission were also assessed. RESULTS: We included 776 patients (326 conventional and 450 temporary ICUs). Thirty-day in-hospital unadjusted mortality (28.8% conventional vs 36.0% temporary, log-rank test p = 0.023) was higher in temporary ICUs. After controlling for potential confounders, hospitalization in temporary ICUs was an independent risk factor associated with mortality (hazard ratio, 1.4; CI, 1.06-1.83; p = 0.016).There were no differences in ICU-free days at 28 days (6; IQR, 0-16 vs 2; IQR, 0-15; p = 0.5) or ventilator-free days at 28 days (8; IQR, 0-16 vs 5; IQR, 0-15; p = 0.6). We observed higher reintubation (18% vs 12%; p = 0.029) and readmission (5% vs 1.6%; p = 0.004) rates in conventional ICUs despite higher use of postextubation noninvasive mechanical ventilation (13% vs 8%; p = 0.025). Use of lung-protective ventilation (87% vs 85%; p = 0.5), prone positioning (76% vs 79%; p = 0.4), neuromuscular blockade (96% vs 98%; p = 0.4), and COVID-19 pharmacologic treatment was similar. CONCLUSIONS AND RELEVANCE: We observed a higher 30-day in-hospital mortality in temporary ICUs. Although both areas had high adherence to evidence-based management, hospitalization in temporary ICUs was an independent risk factor associated with mortality.
Bibliography:Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's website (http://journals.lww.com/ccejournal). Drs. Jimenez and Sifuentes-Osornio conceptualized and designed the study as well interpreted and analyzed the results of this study. Dr. Olivas-Martinez analyzed, interpreted, and elaborated the figures for this study. Drs. Jimenez, Rios-Olais, Ayala-Aguillón, Gil- López, Leal-Villarreal, Rodríguez-Crespo, Jasso-Molina, Enamorado-Cerna, Dardón-Fierro, Martínez-Guerra, Román-Montes, Alvarado-Avila, Juárez-Meneses, Morales-Paredes, Chávez-Suárez, Gutierrez-Espinoza, and Hyzy contributed to the study design, data collection and interpretation, and the writing of the article. Drs. Jimenez, Najera-Ortíz, Martínez-Becerril, Gonzalez-Lara, Ponce de León-Garduño, Baltazar-Torres, Rivero-Sigarroa, Dominguez-Cherit, Hyzy, and Kershenobich contributed to the article's data interpretation, analysis, and writing. Dr. Hyzy serves on the advisory board for Merck, Boehringer Ingelheim, consultant for Cour Pharmaceuticals, and NOTA-Laboratories. He has textbook royalties from Springer Website and UpToDate Grants: CHEST Foundation, National Heart, Lung, and Blood Institute Prevention and Early Treatment of Acute Lung Injury Network Medicolegal Expert witness work. The remaining authors have disclosed that they do not have any potential conflicts of interest. The datasets used and analyzed in this study are available from the corresponding author on reasonable request. For information regarding this article, E-mail: jose.sifuenteso@incmnsz.mx
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2639-8028
2639-8028
DOI:10.1097/CCE.0000000000000668